Latest AL-S Pharma News & Updates

See the latest news and media coverage for AL-S Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AL-S Pharma

Biotechnology company developing ALS therapies

al-spharma.com
Founded year
2016
Company type
Private company
Number of employees
10–50

Last updated

Latest news about AL-S Pharma

In short: AL-S Pharma presented positive Phase 2 findings for its ALS drug AP-101 and announced plans for a Phase 3 clinical trial.

Company announcements

AL-S Pharma

AL-S Pharma discusses AP-101 Phase 2 data

Chief Medical Officer Angela Genge highlights survival improvements and biomarker reductions in ALS patients. Next steps follow Phase 2 success.

AL-S Pharma

AL-S Pharma shares Phase 2 data for AP-101 at AD/PD

Dr. Angela Genge presents on March 19, 2026, in Copenhagen. AP-101 targets misfolded SOD1 in ALS patients.

Unlock all announcements with a

Media coverage

MarketWatch

Additional Phase 2 Data of AL-S Pharma's Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

The MarketWatch News Department was not involved in the creation of this content. Results supported by key neuroaxonal injury biomarkers pNfH and NfL after six...

Unlock all articles with a

Never miss news about AL-S Pharma

Track AL-S Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AL-S Pharma competitors & trending companies

Browse news for competitors to AL-S Pharma and other trending companies.